EUVIMEDEUVIMED entdecken
Open Access

RENEB Inter-Laboratory Comparison 2021: Inter-Assay Comparison of Eight Dosimetry Assays

M Port, J-F Barquinero, D Endesfelder, J Moquet, U Oestreicher, G Terzoudi, F Trompier, A Vral, Y Abe, L Ainsbury, L Alkebsi, S A Amundson und 48 weitere

Radiation Research · 04.04.2023 · 199 (6) · 535-555

DOI: 10.1667/rade-22-00207.1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Radiation Research, erschienen am 04.04.2023. Verfasst von M Port und 59 weiteren Autor:innen. Beteiligte Einrichtung: Bundeswehr Institute of Radiobiology, Munich, Germany. Hauptthemen laut MEDLINE: Biological Assay, Blood Specimen Collection. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tools for radiation exposure reconstruction are required to support the medical management of radiation victims in radiological or nuclear incidents. Different biological and physical dosimetry assays can be used for various exposure scenarios to estimate the dose of ionizing radiation a person has absorbed. Regular validation of the techniques through inter-laboratory comparisons (ILC) is essential to guarantee high quality results. In the current RENEB inter-laboratory comparison, the performance quality of established cytogenetic assays [dicentric chromosome assay (DCA), cytokinesis-block micronucleus assay (CBMN), stable chromosomal translocation assay (FISH) and premature chromosome condensation assay (PCC)] was tested in comparison to molecular biological assays [gamma-H2AX foci (gH2AX), gene expression (GE)] and physical dosimetry-based assays [electron paramagnetic resonance (EPR), optically or thermally stimulated luminescence (LUM)]. Three blinded coded samples (e.g., blood, enamel or mobiles) were exposed to 0, 1.2 or 3.5 Gy X-ray reference doses (240 kVp, 1 Gy/min). These doses roughly correspond to clinically relevant groups of unexposed to low exposed (0–1 Gy), moderately exposed (1–2 Gy, no severe acute health effects expected) and highly exposed individuals (>2 Gy, requiring early intensive medical care). In the frame of the current RENEB inter-laboratory comparison, samples were sent to 86 specialized teams in 46 organizations from 27 nations for dose estimation and identification of three clinically relevant groups. The time for sending early crude reports and more precise reports was documented for each laboratory and assay where possible. The quality of dose estimates was analyzed with three different levels of granularity, 1. by calculating the frequency of correctly reported clinically relevant dose categories, 2. by determining the number of dose estimates within the uncertainty intervals recommended for triage dosimetry (±0.5 Gy or ±1.0 Gy for doses 2.5 Gy), and 3. by calculating the absolute difference (AD) of estimated doses relative to the reference doses. In total, 554 dose estimates were submitted within the 6-week period given before the exercise was closed. For samples processed with the highest priority, earliest dose estimates/categories were reported within 5–10 h of receipt for GE, gH2AX, LUM, EPR, 2–3 days for DCA, CBMN and within 6–7 days for the FISH assay. For the unirradiated control sample, the categorization in the correct clinically relevant group (0–1 Gy) as well as the allocation to the triage uncertainty interval was, with the exception of a few outliers, successfully performed for all assays. For the 3.5 Gy sample the percentage of correct classifications to the clinically relevant group (≥2 Gy) was between 89–100% for all assays, with the exception of gH2AX. For the 1.2 Gy sample, an exact allocation to the clinically relevant group was more difficult and 0–50% or 0–48% of the estimates were wrongly classified into the lowest or highest dose categories, respectively. For the irradiated samples, the correct allocation to the triage uncertainty intervals varied considerably between assays for the 1.2 Gy (29–76%) and 3.5 Gy (17–100%) samples. While a systematic shift towards higher doses was observed for the cytogenetic-based assays, extreme outliers exceeding the reference doses 2–6 fold were observed for EPR, FISH and GE assays. These outliers were related to a particular material examined (tooth enamel for EPR assay, reported as kerma in enamel, but when converted into the proper quantity, i.e. to kerma in air, expected dose estimates could be recalculated in most cases), the level of experience of the teams (FISH) and methodological uncertainties (GE). This was the first RENEB ILC where everything, from blood sampling to irradiation and shipment of the samples, was organized and realized at the same institution, for several biological and physical retrospective dosimetry assays. Almost all assays appeared comparably applicable for the identification of unexposed and highly exposed individuals and the allocation of medical relevant groups, with the latter requiring medical support for the acute radiation scenario simulated in this exercise. However, extreme outliers or a systematic shift of dose estimates have been observed for some assays. Possible reasons will be discussed in the assay specific papers of this special issue. In summary, this ILC clearly demonstrates the need to conduct regular exercises to identify research needs, but also to identify technical problems and to optimize the design of future ILCs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biological AssayBlood Specimen CollectionRetrospective StudiesCytokinesisElectron Spin Resonance Spectroscopy

Autor:innen und Institutionen

  • Bundeswehr Institute of Radiobiology, Munich, Germany.
  • Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Bundesamt für Strahlenschutz, Oberschleißheim, Germany.
  • UK Health Security Agency, Radiation, Chemical and Environmental Hazards Division, Oxfordshire, United Kingdom.
  • National Centre for Scientific Research "Demokritos", Health Physics, Radiobiology & Cytogenetics Laboratory, Agia Paraskevi, Greece.
  • Institut de Radioprotection et de Surete Nucleaire, Fontenay aux Roses, France.

Förderung

  • NIAID NIH HHS

Zitieren

APA

Port, M., Barquinero, J. F., Endesfelder, D., Moquet, J., Oestreicher, U., Terzoudi, G., Trompier, F., Vral, A., Abe, Y., Ainsbury, L., Alkebsi, L., Amundson, S. A., Badie, C., Baeyens, A., Balajee, A. S., Balázs, K., Barnard, S., Bassinet, C., Beaton-Green, L. A., …, & Monteiro Gil, O. (2023). RENEB Inter-Laboratory Comparison 2021: Inter-Assay Comparison of Eight Dosimetry Assays. Radiation Research, 199(6), 535-555. https://doi.org/10.1667/rade-22-00207.1

Vancouver

Port M, Barquinero JF, Endesfelder D, Moquet J, Oestreicher U, Terzoudi G, et al. RENEB Inter-Laboratory Comparison 2021: Inter-Assay Comparison of Eight Dosimetry Assays. Radiation Research. 2023;199(6):535-555. doi:10.1667/rade-22-00207.1

BibTeX
@article{Port2023,
  author = {Port, M and Barquinero, J-F and Endesfelder, D and Moquet, J and Oestreicher, U and Terzoudi, G and Trompier, F and Vral, A and Abe, Y and Ainsbury, L and Alkebsi, L and Amundson, S A and Badie, C and Baeyens, A and Balajee, A S and Balázs, K and Barnard, S and Bassinet, C and Beaton-Green, L A and Beinke, C and Bobyk, L and Brochard, P and Brzoska, K and Bucher, M and Ciesielski, B and Cuceu, C and Discher, M and D Oca, M C and Domínguez, I and Doucha-Senf, S and Dumitrescu, A and Duy, P N and Finot, F and Garty, G and Ghandhi, S A and Gregoire, E and Goh, V S T and Güçlü, I and Hadjiiska, L and Hargitai, R and Hristova, R and Ishii, K and Kis, E and Juniewicz, M and Kriehuber, R and Lacombe, J and Lee, Y and Lopez Riego, M and Lumniczky, K and Mai, T T and Maltar-Strmečki, N and Marrale, M and Martinez, J S and Marciniak, A and Maznyk, N and McKeever, S W S and Meher, P K and Milanova, M and Miura, T and Monteiro Gil, O},
  title = {RENEB Inter-Laboratory Comparison 2021: Inter-Assay Comparison of Eight Dosimetry Assays},
  journal = {Radiation Research},
  year = {2023},
  volume = {199},
  number = {6},
  pages = {535--555},
  doi = {10.1667/rade-22-00207.1}
}
Kostenlos starten →